Circular RNAs are differentially expressed in prostate cancer and are potentially associated with resistance to enzalutamide-Reference-Cited by-同舟云学术

Circular RNAs are differentially expressed in prostate cancer and are potentially associated with resistance to enzalutamide

Published:2019-07-24 Issue:1 Volume:9 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Greene John,Baird Anne-Marie,Casey Orla,Brady Lauren,Blackshields Gordon^ORCID,Lim Marvin,O’Brien Odharnaith,Gray Steven G.^ORCID,McDermott Raymond,Finn Stephen P.^ORCID

Funder

Irish Cancer Society

Prostate Cancer Foundation

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-019-47189-2.pdf

Reference57 articles.

1. Nelson, W. G., De Marzo, A. M. & Isaacs, W. B. Prostate Cancer. New England Journal of Medicine 349, 366–381, https://doi.org/10.1056/NEJMra021562 (2003).

2. Heidenreich, A. et al. EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer. Eur Urol 65, 467–479, https://doi.org/10.1016/j.eururo.2013.11.002 (2014).

3. Mellado, B., Codony, J., Ribal, M. J., Visa, L. & Gascon, P. Molecular biology of androgen-independent prostate cancer: the role of the androgen receptor pathway. Clinical & translational oncology: official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 11, 5–10 (2009).

4. Scher, H. I. et al. Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy. New England Journal of Medicine 367, 1187–1197, https://doi.org/10.1056/NEJMoa1207506 (2012).

5. Beer, T. M. et al. Enzalutamide in metastatic prostate cancer before chemotherapy. The New England journal of medicine 371, 424–433, https://doi.org/10.1056/NEJMoa1405095 (2014).

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overcoming chemoresistance and radio resistance in prostate cancer: The emergent role of non-coding RNAs;Pathology - Research and Practice;2024-03

2. New Molecular Markers for Prostate Cancer Diagnosis;UROL J;2024

3. Androgen receptor-dependent mechanisms mediating therapy resistance in prostate cancer;Therapy Resistance in Prostate Cancer;2024

4. Cellular senescence: A potential mode of circular RNAs regulating prostate cancer;MedComm – Oncology;2023-12

5. Research Progress on the Mechanism of Androgen Receptor Signaling Pathway in Castration-Resistant Prostate Cancer;annals of urologic oncology;2023-11-11